Navigation Links
QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
Date:10/30/2007

VENLO, The Netherlands, Oct. 30 /PRNewswire-FirstCall/ -- In conjunction with QIAGEN's Third Quarter 2007 Earnings release, you are invited to listen to its conference call which will be broadcast live over the Internet on Tuesday, November 6, 2007 at 9:30 a.m. EST, with Peer M. Schatz, President and Chief Executive Officer and Roland Sackers, Chief Financial Officer.

What: QIAGEN N.V. -- Third Quarter 2007 Earnings Announcement

When: Tuesday, November 6, 2007 at 9:30 a.m. EST

Where: http://www.QIAGEN.com/goto/061107

How: Live over the Internet -- Simply log on to the Web at the

address above.

The corresponding presentation slides are available to download

in the investor relations section of QIAGEN's website at:

http://www.QIAGEN.com/goto/061107

Contact: Andreas Marathovouniotis, Russo Partners, 212-845-4253

QIAGEN N.V., a Netherlands holding company, is a leading provider of innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. QIAGEN has developed a comprehensive portfolio of more than 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification. QIAGEN also supplies diagnostic kits, tests, and assays for human and veterinary molecular diagnostics. The company's products are sold to academic research markets, and to leading pharmaceutical and biotechnology companies; as well as to diagnostics laboratories. QIAGEN also provides purification and testing solutions to applied testing markets: such as forensics, animal or food testing, and pharmaceutical process control.

QIAGEN employs more than 2,600 people worldwide. QIAGEN products are sold through a dedicated sale
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
2. Neurologix to Present at the Third Annual C.E. Unterberg Towbin Emerging Growth Conference
3. Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke
4. Can-Fite Proceeds with Development of Third Drug; Progress in Development of CF502 Will Be Presented at the Annual European Congress of Rheumatology
5. One-Third of Patients Discontinue Common Breast Cancer Therapy
6. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
7. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
8. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
9. ViaCell to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Accelrys to Present to Investors at C.E. Unterberg Emerging Growth Opportunities Conference
11. Metabasis to Present at C.E. Unterberg, Towbin Emerging Growth Conference and Attend Pacific Growth Equities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Colo. , July 29, 2014 New ... (MARC) which could allow physicians to see and assess ... hold promise, according to study authors who released their ... 11 th Annual Meeting in Colorado ... to advance the field of neurointervention, a specialty that ...
(Date:7/29/2014)... , July 29, 2014 Numotion,s Board of ... Mike Swinford will be the company,s new Chief Executive ... successful 22-year career at GE where he worked primarily for ... annual revenue to over $5 billion. His most recent position ... "I am thrilled to join Numotion," said ...
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- MHG Medical ... has launched its Medical Equipment and X-ray ... services are tailored to the cruise industry,s unique ... industry operators to propose that they should develop ... new program is intended to create standardized processes ...
Breaking Medicine Technology:New Technology May Improve Visualization Of The Brain During Stroke Treatment 2New Technology May Improve Visualization Of The Brain During Stroke Treatment 3Numotion Names Mike Swinford CEO 2MHG Medical Management Services Aims to Change Cruise Industry Standard With New Equipment Maintenance Program 2
... OAKS, Calif. and INGELHEIM, Germany, Jan. 18, 2011 ... Ingelheim today announced they have signed an agreement under ... substantially all assets at Amgen,s Fremont California development and ... by the board of directors of each company and ...
... The U.S. Food and Drug Administration today approved Natroba ... lice infestation in patients ages 4 years and older. ... Head lice are parasitic insects found on people,s head, ... times a day but are not known to cause ...
Cached Medicine Technology:Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility 2Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility 3Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility 4Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility 5FDA Approves Head Lice Treatment for Children and Adults 2
(Date:7/29/2014)... The best way to cure most cases of cancer ... of this approach, however, is that the surgeon may ... local recurrence. , With a new technique, researchers at ... to help surgeons see the entire tumor in the ... approach relies on an injectable dye that accumulates in ...
(Date:7/29/2014)... Washington, DC (PRWEB) July 29, 2014 ... Accreditation, filmed during the 2014 Society for Cardiovascular Angiography ... will be released this week. The videos review the ... in accreditation services for the cardiac catheterization laboratory from ... , In the first video, Jane Kiah, MS, RN, ...
(Date:7/29/2014)... measuring "adaptive behavior" in boys with fragile X ... the largest longitudinal study of the inherited disorder ... a range of everyday social and practical skills, ... living such as getting dressed. In this study, ... with fragile X, in that it did not ...
(Date:7/29/2014)... The National Congress of American Indians (NCAI) and ... NFL team owner Dan Snyder asking him to disavow suggestions ... is emanating from “well-intentioned elites” who are “not Native Americans.” ... respond. , The Change the Mascot campaign today ... was first reported by Erik Brady of USA Today.* ...
(Date:7/29/2014)... Florida (PRWEB) July 29, 2014 Botanica Day ... having performed more than 12,000 Brazilian bikini waxes ... this milestone achievement, the spa has rolled out a number ... services. Those new to Botanica can now get a free ... , The iconic day spa located in downtown Clearwater, ...
Breaking Medicine News(10 mins):Health News:Penn team makes cancer glow to improve surgical outcomes 2Health News:Penn team makes cancer glow to improve surgical outcomes 3Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Launches 3-Part Video Series: The Cost/Benefit of ACE Accreditation; ProMedica Toledo Hospital Achieves Accreditation 3Health News:Socialization relative strength in fragile X longitudinal study 2Health News:Native American Groups Urge Washington Team Owner Dan Snyder to Stop Claiming Name Change Issue Driven by "Elites" Who Are Not People of Color 2Health News:Award-Winning Botanica Day Spa Celebrates 12,000 Brazilian Bikini Waxes 2Health News:Award-Winning Botanica Day Spa Celebrates 12,000 Brazilian Bikini Waxes 3
... seeks insights into chronic, illnesses, including heart failure and COPD, ... ... VENTURA, Calif., Oct. 8 VivoMetrics announced today,that noted researcher Bruce D. ... VivoMetrics LifeShirt(R) System to,the South Pole to collect valuable data for his ...
... Oct. 8 NPS Pharmaceuticals,Inc. (Nasdaq: NPSP ... as,senior vice president and chief commercial officer, effective ... NPS executive team, Mr. O,Callaghan will be,responsible for ... activities, including the commercial development of NPS,s,late-stage products ...
... The Physicians Coalition,for Injectable Safety today issued ... lipolysis or other injectable treatments touted to,reduce localized ... not,be mistaken as an accepted medical or cosmetic ... fat, using compounded pharmaceuticals, or,herbal agents, claim a ...
... the stories of eight mothers who survived ... breast ... product and baby gear brand, celebrates the "Power of Pink" by,announcing the ... Month, the eight outstanding women will be recognized,during the Susan G. Komen ...
... NEW YORK, Oct. 8 Health Management Systems,Inc. ... business of Peer Review,Systems, Inc. d/b/a/ Permedion, an ... in Westerville, Ohio. With this,acquisition, HMS augments its ... offerings for state Medicaid agencies and,managed care organizations. ...
... likely than whites to get tamoxifen, for example , , MONDAY, ... that has spread to the lymph nodes are less likely ... chemotherapy than white women with the same level of disease ... to the lymph nodes, we are seeing that African-American women ...
Cached Medicine News:Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 2Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 3Health News:NPS Pharmaceuticals Names Brian O'Callaghan as New Chief Commercial Officer 2Health News:Consumer Safety Alert on Fat Dissolving Injections 2Health News:Consumer Safety Alert on Fat Dissolving Injections 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 4Health News:HMS Acquires Permedion to Expand Clinical Review Capabilities 2Health News:Black Women Get Less Breast Cancer Treatment 2Health News:Black Women Get Less Breast Cancer Treatment 3
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... range of Milli-Q ultrapure water systems ... requirements. Each of the five new ... target contaminants detrimental to particular applications ... ICP-MS. The systems incorporate a high ...
... a range of Milli-Q ultrapure water ... quality requirements. Each of the five ... specifically target contaminants detrimental to particular ... and ICP-MS. The systems incorporate a ...
Medicine Products: